Samsara BioCapital, L.P. 13D and 13G filings for Chinook Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2023-11-22 4:15 pm Sale |
2023-08-11 | 13D | Chinook Therapeutics, Inc. KDNY |
Samsara BioCapital, L.P. | 0 0.000% |
-5,181,557 (Position Closed) |
Filing |
| 2022-06-01 4:00 pm Purchase |
2020-10-05 | 13D | Chinook Therapeutics, Inc. KDNY |
Samsara BioCapital, L.P. | 5,181,557 8.400% |
5,181,557 (New Position) |
Filing |